U.S. AN2 Therapeutics, Ecolab, RPM International
May 16 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AN2 Therapeutics, Ecolab and RPM International, on Thursday.
HIGHLIGHTS
* AN2 Therapeutics Inc ANTX.O: Evercore ISI cuts target price to $2 from $7 |
* Biolife Solutions Inc BLFS.O: Maxim Group raises target price to $30 from $25 |
* Ecolab Inc ECL.N: Evercore ISI raises target price to $250 from $195 |
* RPM International Inc RPM.N: Evercore ISI raises target price to $130 from $110 |
* Third Harmonic Bio Inc THRD.O: Jefferies raises target price to $15 from $8.1 |
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Airbnb Inc ABNB.O: Bernstein raises target price to $184 from $179 |
* Allete Inc ALE.N: Mizuho raises target price to $67 from $57 |
* Allogene Therapeutics Inc ALLO.O: H.C. Wainwright cuts target price to $9 from $10 |
* Amphenol Corp APH.N: Evercore ISI raises target price to $150 from $130 |
* AN2 Therapeutics Inc ANTX.O: Evercore ISI cuts target price to $2 from $7 |
* Analog Devices ADI.O: Oppenheimer raises target price to $245 from $215 |
* Analog Devices Inc ADI.O: Oppenheimer raises target price to $245 from $215 |
* Applied Materials Inc AMAT.O: Susquehanna raises target price to $185 from $160 |
* Arcutis Biotherapeutics Inc ARQT.O: Guggenheim raises target price to $27 from $26 |
* ARM Holdings Plc ARM.O: Bernstein raises target price to $92 from $72 |
* Ashland Inc ASH.N: Evercore ISI raises target price to $100 from $95 |
* Axalta Coating Systems Ltd AXTA.N: Citigroup raises target price to $41 from $40 |
* Axalta Coating Systems Ltd AXTA.N: Jefferies raises target price to $39 from $36 |
* Biolife Solutions Inc BLFS.O: Maxim Group raises target price to $30 from $25 |
* Black Diamond Therapeutics, Inc. BDTX.O: H.C. Wainwright cuts target to $11 from $12 |
* Booking Holdings Inc BKNG.O: Bernstein raises target price to $3874 from $3636 |
* Btcs Inc. BTCS.O: H.C. Wainwright raises target price to $39.4 from $26.7 |
* Cabaletta Bio Inc CABA.O: Jefferies cuts target price to $31 from $36 |
* Cargo Therapeutics Inc CRGX.O: Truist Securities cuts target price to $32 from $34 |
* Celanese Corp CE.N: Evercore ISI raises target price to $170 from $150 |
* Celcuity Inc. CELC.O: Craig-Hallum raises target price to $27 from $25 |
* Cirrus Logic Inc CRUS.O: Benchmark cuts to hold from buy |
* Cisco CSCO.O: Jefferies raises target price to $56 from $55 |
* Cisco CSCO.O: Wells Fargo raises target price to $57 from $52 |
* Cisco Systems CSCO.O: Oppenheimer raises target price to $58 from $54 |
* Cisco Systems CSCO.O: Wells Fargo raises target price to $57 from $52 |
* Commvault Systems, Inc. CVLT.O: Wells Fargo raises target price to $140 from $125 |
* Corebridge Financial Inc CRBG.N: Evercore ISI raises target price to $34 from $31 |
* Coterra Energy Inc CTRA.N: Truist Securities raises target price to $35 from $27 |
* Coterra Energy Inc CTRA.N: Truist Securities raises to buy from hold |
* Cracker Barrel Old Country Store Inc CBRL.O: BofA Global Research cuts price objective to $62 from $72 |
* Cullinan Therapeutics, Inc. CGEM.O: H.C. Wainwright cuts target price to $28 from $29 |
* Dare Bioscience Inc DARE.O: Jonestrading cuts target price to $5 from $6 |
* Dell Technologies Inc DELL.N: Evercore ISI raises target price to $165 from $140 |
* Devon Energy Corp DVN.N: Gerdes Energy Research raises to buy from neutral |
* Dianthus Therapeutics Inc DNTH.O: H.C. Wainwright initiates coverage with buy rating |
* Dianthus Therapeutics Inc DNTH.O: H.C. Wainwright initiates coverage with target $40 |
* Dillard'S Inc DDS.N: JP Morgan raises target price to $369 from $294 |
* Dragonfly Energy Holdings Corp DFLI.O: Stifel raises target price to $1.2 from $1 |
* Dutch Bros Inc BROS.N: Wedbush raises target price to $45 from $39 |
* Dynatrace Inc DT.N: BMO cuts target price to $54 from $55 |
* Dynatrace Inc DT.N: BTIG cuts target price to $57 from $66 |
* Dynatrace Inc DT.N: Guggenheim cuts target price to $60 from $68 |
* Dynatrace Inc DT.N: RBC cuts target price to $60 from $66 |
* Dynatrace Inc DT.N: TD Cowen raises target price to $60 from $58 |
* Dynatrace Inc DT.N: Truist Securities cuts target price to $60.00 from $70.00 |
* Dynatrace Inc DT.N: Wells Fargo cuts target price to $60 from $75 |
* Eastman Chemical Co EMN.N: Evercore ISI raises target price to $118 from $98 |
* Ecolab Inc ECL.N: Evercore ISI raises target price to $250 from $195 |
* Enterprise Products Partners LP EPD.N: JP Morgan cuts target price to $32 from $33 |
* EOG Resources Inc EOG.N: Truist Securities cuts target price to $136 from $163 |
* EOG Resources Inc EOG.N: Truist Securities cuts to hold from buy |
* Eos Energy Enterprises Inc EOSE.O: Evercore ISI cuts target price to $3 from $7 |
* Eos Energy Enterprises Inc EOSE.O: TD Cowen cuts target price to $2.5 from $3 |
* European Wax Center EWCZ.O: BofA Global Research cuts price objective to $16 from $19 |
* European Wax Center EWCZ.O: Citigroup cuts target price to $16 from $19 |
* European Wax Center Inc EWCZ.O: Telsey Advisory Group cuts target price to $16 from $18 |
* European Wax Center Inc EWCZ.O: Truist Securities cuts target price to $16.00 from $17.00 |
* Expedia Group Inc EXPE.O: Bernstein cuts target price to $118 from $136 |
* Extreme Networks, Inc. EXTR.O: Craig-Hallum raises target price to $14 from $13 |
* Extreme Networks, Inc. EXTR.O: Craig-Hallum raises to buy from hold |
* Fate Therapeutics Inc FATE.O: H.C. Wainwright cuts target price to $5 from $7 |
* Flowers Foods Inc FLO.N: Stephens raises target price to $27 from $24 |
* Goodrx Holdings Inc GDRX.O: Leerink Partners raises target price to $12 from $11 |
* Goodrx Holdings Inc GDRX.O: Raymond James raises to outperform from market perform |
* Goodrx Holdings Inc GDRX.O: TD Cowen raises target price to $16 from $14 |
* Hain Celestial Group Inc HAIN.O: D.A. Davidson cuts target price to $8 from $10 |
* Hess Corp HES.N: Susquehanna raises target price to $167 from $164 |
* HP Inc HPQ.N: BofA Global Research raises price objective to $35 from $32 |
* Hut 8 Corp HUT.O: Craig-Hallum raises to buy from hold |
* Hut 8 Corp HUT.O: Needham raises target price to $13 from $12 |
* Idacorp Inc IDA.N: Mizuho raises target price to $99 from $88 |
* Iheartmedia Inc IHRT.O: Guggenheim cuts target price to $3 from $5 |
* Impinj Inc PI.O: Needham raises target price to $195.00 from $160.00 |
* Inotiv, Inc. NOTV.O: Craig-Hallum cuts target price to $10 from $25 |
* International Game Technology Plc IGT.N: Jefferies cuts target price to $23 from $26 |
* Jack In the Box Inc JACK.O: Stifel cuts target price to $60 from $75 |
* Kimco Realty Corp KIM.N: BMO cuts target price to $22 from $23 |
* Kodiak Sciences Inc KOD.O: Jefferies cuts target price to $4 from $7 |
* Kosmos Energy Ltd KOS.N: Jefferies raises target price to $7.65 from $7.3 |
* Magnite, Inc. MGNI.O: Craig-Hallum raises target price to $20 from $18 |
* Manhattan Associates Inc MANH.O: D.A. Davidson raises target price to $260 from $240 |
* Molina Healthcare Inc MOH.N: Stephens cuts target price to $355 from $390 |
* NCR Atleos Corp NATL.N: D.A. Davidson raises target price to $48 from $30 |
* Netflix Inc NFLX.O: Benchmark raises target price to $450 from $440 |
* New Fortress Energy Inc NFE.O: Capital One Securities cuts target price to $32 from $34 |
* Newmont NEM.N: Bernstein cuts target price to $45 from $46 |
* Nextracker Inc NXT.O: HSBC cuts target price to $60 from $65 |
* Northwestern Corp NWE.O: Mizuho raises target price to $52 from $51 |
* Occidental Petroleum Corp OXY.N: Truist Securities cuts target price to $69 from $84 |
* Occidental Petroleum Corp OXY.N: Truist Securities cuts to hold from buy |
* Olema Pharmaceuticals Inc OLMA.O: H.C. Wainwright raises target price to $30 from $28 |
* Palo Alto Networks Inc PANW.O: JP Morgan raises target price to $340 from $330 |
* Perspective Therapeutics Inc CATX.A: Jonestrading raises PT to $2.20 from $1.50 |
* Portland General Electric Co POR.N: Mizuho raises target price to $45 from $42 |
* Prime Medicine Inc PRME.O: Citigroup raises to buy from neutral |
* Progressive Corp PGR.N: BMO raises target price to $235 from $234 |
* Prospect Capital Corp PSEC.O: Wells Fargo cuts target price to $5 from $5.5 |
* Prospect Capital Corporation PSEC.O: Wells Fargo cuts target price to $5 from $5.5 |
* Ralph Lauren Corp RL.N: UBS raises target price to $250 from $244 |
* Rani Therapeutics Holdings Inc RANI.O: UBS raises target price to $8 from $4 |
* Retail Opportunity Investments Corp ROIC.O: BMO cuts target price to $13.5 from $14 |
* Reviva Pharmaceuticals Holdings Inc RVPH.O: Maxim Group cuts PT to $6 from $18 |
* RPM International Inc RPM.N: Evercore ISI raises target price to $130 from $110 |
* Savara Inc SVRA.O: Evercore ISI cuts target price to $7 from $10 |
* Sharkninja Inc SN.N: BofA Global Research initiates coverage with buy rating |
* Sharkninja Inc SN.N: BofA Global Research initiates coverage with price objective $90 |
* Solid Biosciences SLDB.O: Barclays cuts target price to $18 from $21 |
* Southwestern Energy Co SWN.N: Susquehanna raises target price to $8 from $7.50 |
* Spire Global Inc SPIR.N: Stifel cuts target price to $20 from $24 |
* Starwood Property Trust Inc STWD.N: Raymond James cuts target price to $23 from $23.50 |
* Sutro Biopharma Inc STRO.O: Wells Fargo cuts target price to $5 from $8 |
* Targa Resources Corp TRGP.N: RBC raises target price to $128 from $123 |
* Tff Pharmaceuticals Inc TFFP.O: Jonestrading cuts target price to $4 from $13 |
* Third Harmonic Bio Inc THRD.O: Jefferies raises target price to $15 from $8.1 |
* Treace Medical Concepts Inc TMCI.O: UBS cuts target price to $6.5 from $16 |
* Treace Medical Concepts Inc TMCI.O: UBS cuts to neutral from buy |
* Truist Financial Corp TFC.N: Stephens raises target price to $47 from $43 |
* Trupanion Inc TRUP.O: BofA Global Research raises to buy from neutral |
* Trupanion Inc TRUP.O: BofA Global Research raises price objective to $49 from $35 |
* Tscan Therapeutics Inc TCRX.O: BTIG initiates coverage with buy rating and $12 PT |
* Ulta Beauty Inc ULTA.O: UBS cuts target price to $550 from $690 |
* under Armour Inc UAA.N: Wedbush cuts target price to $8 from $10 |
* Urban Outfitters Inc URBN.O: UBS raises target price to $43 from $42 |
* Vislink Technologies Inc VISL.O: Alliance Global Partners raises PT to $12 from $10 |
* Workday Inc WDAY.O: BofA Global Research cuts price objective to $310 from $330 |
* Xtant Medical Holdings XTNT.A: Craig-Hallum cuts target price to $1.7 from $1.85 |
* Zebra Technologies Corp ZBRA.O: Needham raises target price to $370.00 from $352.00 |
* Zimvie Inc ZIMV.O: Needham raises to buy from hold |
* Zscaler Inc ZS.O: Stifel cuts target price to $220 from $270 |
(Compiled by Bengaluru Newsroom)
</body></html>Související aktiva
Poslední novinky
Zřeknutí se odpovědnosti: Subjekty skupiny XM Group poskytují služby a přístup do naší online obchodní platformy v režimu „execution-only”, což osobám umožní prohlížet a/nebo použít obsah, dostupný zde nebo prostřednictvím webové stránky, který není určený ke změně nebo šíření. Na takový přístup a použití se vždy vztahují: (i) Všeobecné obchodní podmínky; (ii) Upozornění na rizika; a (iii) Úplné zřeknutí se odpovědnosti. Takový obsah je proto poskytovaný pouze jako obecné informace. Mějte především na paměti, že obsah naší online obchodní platformy není ani žádostí, ani nabídkou vstupu do jakýchkoliv transakcí na finančních trzích. Obchodování na jakémkoliv finančním trhu zahrnuje významnou úroveň rizika pro váš kapitál.
Veškerý materiál, zveřejněný na naší online obchodní platformě, je určený pouze pro vzdělávací/informační účely a neobsahuje ani by neměl být považovaný za finanční, investiční, daňové nebo obchodní rady a doporučení, ani záznamy o našich obchodních cenách, nebo nabídku transakce s jakýmikoliv finančními instrumenty, či nevyžádadnou propagaci pro vaši osobu.
Jakýkoliv obsah třetích stran a také obsah, připravený společností XM, jako jsou názory, novinky, výzkum, analýzy, ceny, další informace nebo odkazy na webové stránky třetích stran, které jsou zobrazeny na tomto webu, jsou poskytovány v neupravené verzi jako obecný tržní komentář, a nepředstavují investiční radu. Pokud je jakýkoliv obsah uváděný jako investiční výzkum, musíte si uvědomit a přijmout, že tento obsah nebyl určený a nebyl připravený v souladu se zákonnými požadavky, vytvořenými pro podporu nezávislosti investičního výzkumu, a jako takový by měl být podle příslušných zákonů a předpisu považovaný pouze za marketingovou komunikaci. Ujistěte se, že jste si přečetli a plně rozumíte našemu Oznámení o seznámení se s riziky a investičním výzkumu, který není nezávislý, týkající se výše uvedených informací, a ke kterým lze přejít zde.
